{"id":"W2518249527","doi":"10.1016/j.ygyno.2016.07.112","title":"Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Centre Hospitalier de l’Université de Montréal","funders":"Amgen","keywords":"Medicine; Paclitaxel; Ascites; Ovarian cancer; Oncology; Progression-free survival; Internal medicine; Overall survival; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002446287,0.001789535,0.002771746,0.0005282377,0.0005616511,0.0009791421,0.0010345,0.001345907,0.002399663],"category_scores_gemma":[0.001491516,0.0004833968,0.002974601,0.0004510479,0.0007471382,0.0006740565,0.0003965336,0.003901203,0.0007910124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001081933,"about_ca_system_score_gemma":0.00185933,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002834658,"about_ca_topic_score_gemma":0.008731226,"domain_scores_codex":[0.9993807,0.000299069,0.00002997727,0.00007276717,0.00006637137,0.0001510223],"domain_scores_gemma":[0.9988775,0.0002507597,0.0001859146,0.0001238483,0.0001099872,0.0004520296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6047224,0.08774871,0.01587332,0.001369695,0.008476278,0.0006963242,0.0006309357,0.007225116,0.06534572,0.0005244394,0.01406442,0.1933226],"study_design_scores_gemma":[0.4076952,0.530964,0.03601481,0.00007537656,0.003218082,0.0006073396,0.000147574,0.001656424,0.01028839,0.0005117517,0.008719882,0.0001012221],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9817593,0.003047971,0.001500678,0.001168474,0.0003552781,0.002559052,0.006663572,0.000209586,0.002736009],"genre_scores_gemma":[0.9689972,0.003115952,0.004254761,0.001935436,0.000252646,0.002684274,0.01264508,0.0001534303,0.005961162],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002834658,"threshold_uncertainty_score":0.01293737,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05375457365311831,"score_gpt":0.3916752352985862,"score_spread":0.3379206616454679,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}